Abstract
Survivin (also termed Birc5) belongs to the family of genes known as inhibitors of apoptosis, and it has been implicated in both prevention of cell death and control of mitosis. The survivin pathway is exploited in cancer, but its potential role in vascular injury is unknown. Here, we show that balloon-mediated arterial injury in rabbits resulted in expression of survivin in vascular cells. Serum or PDGF-AB stimulated survivin expression in cultured smooth-muscle cells (SMCs), which suppressed apoptosis and prevented caspase activation. Adenoviral delivery of a phosphorylation-defective survivin mutant reversed the cytoprotective effect of PDGF in SMCs without affecting mitotic progression, suppressed neointimal formation in wire-injured mouse femoral arteries, and induced vascular cell apoptosis in vivo. These data identify survivin as a critical regulator of SMC apoptosis after acute vascular injury. Disrupting the survivin pathway may provide a novel therapy to limit pathological vessel-wall remodeling.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Hengartner, M.O. The biochemistry of apoptosis. Nature 407, 770–776 (2000).
Reed, J.C. Dysregulation of apoptosis in cancer. J. Clin. Oncol. 17, 2941–2953 (1999).
Walsh, K., Smith, R.C. & Kim, H.-S. Vascular cell apoptosis in remodeling, restenosis, and plaque rupture. Circ. Res. 87, 184–188 (2000).
Ross, R. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 362, 801–809 (1993).
Choy, J.C., Granville, D.J., Hunt, D.J. & McManus, B.M. Endothelial cell apoptosis: Biochemical characteristics and potential implications for atherosclerosis. J. Mol. Cell Cardiol. 33, 1673–1690 (2001).
Perlman, H., Maillard, L., Krasinski, K. & Walsh, K. Evidence for the rapid onset of apoptosis in medial smooth muscle cells after balloon injury. Circulation 95, 981–987 (1997).
Niemann-Jonsson, A. et al. Increased rate of apoptosis in intimal arterial smooth muscle cells through endogenous activation of TNF receptors. Arterioscler. Thromb. Vasc. Biol. 21, 1909–1914 (2001).
Schaub, F.J. et al. Fas/FADD-mediated activation of a specific program of inflammatory gene expression in vascular smooth muscle cells. Nature Med. 6, 790–796 (2000).
Okura, Y. et al. Oxidized low-density lipoprotein is associated with apoptosis of vascular smooth muscle cells in human atherosclerotic plaques. Circulation 102, 2680–2686 (2000).
Bennett, M.R. Apoptosis of vascular smooth muscle cells in vascular remodelling and atherosclerotic plaque rupture. Cardiovasc. Res. 41, 361–368 (1999).
Miyamoto, T., Leconte, I., Swain, J.L. & Fox, J.C. Autocrine FGF signaling is required for vascular smooth muscle cell survival in vitro. J. Cell Physiol. 177, 58–67 (1998).
Obata, H. et al. NF-κB is induced in the nuclei of cultured rat aortic smooth muscle cells by stimulation of various growth factors. Biochem. Biophys. Res. Commun. 224, 27–32 (1996).
Perlman, H. et al. Adenovirus-encoded hammerhead ribozyme to Bcl-2 inhibits neointimal hyperplasia and induces vascular smooth muscle cell apoptosis. Cardiovasc. Res. 45, 570–578 (2000).
Hayakawa, Y. et al. Apoptosis and overexpression of bax protein and bax mRNA in smooth muscle cells within intimal hyperplasia of human radial arteries: Analysis with arteriovenous fistulas used for hemodialysis. Arterioscler. Thromb. Vasc. Biol. 19, 2066–2077 (1999).
Pollman, M.J., Hall, J.L., Mann, M.J., Zhang, L. & Gibbons, G.H. Inhibition of neointimal cell bcl-x expression induces apoptosis and regression of vascular disease. Nature Med. 4, 222–227 (1998).
Ekhterae, D. et al. Bcl-2 decreases voltage-gated K+ channel activity and enhances survival in vascular smooth muscle cells. Am. J. Physiol. Cell Physiol. 281, C157–165 (2001).
Deveraux, Q.L. & Reed, J.C. IAP family proteins-suppressors of apoptosis. Genes Dev. 13, 239–252 (1999).
Altieri, D.C. The molecular basis and potential role of survivin in cancer diagnosis and therapy. Trends Mol. Med. 7, 542–547 (2001).
Hoffman, W.H., Biade, S., Zilfou, J.T., Chen, J. & Murphy, M. Transcriptional repression of the anti-apoptotic survivin gene by wild type p53. J. Biol. Chem. 277, 3247–3257 (2001).
Tran, J. et al. Marked induction of the IAP family antiapoptotic proteins survivin and XIAP by VEGF in vascular endothelial cells. Biochem. Biophys. Res. Commun. 264, 781–788 (1999).
O'Connor, D.S. et al. Control of apoptosis during angiogenesis by survivin expression in endothelial cells. Am. J. Pathol. 156, 393–398 (2000).
Papapetropoulos, A. et al. Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway. J. Biol. Chem. 275, 9102–9105 (2000).
Mesri, M. et al. Suppression of vascular endothelial growth factor-mediated endothelial cell protection by survivin targeting. Am. J. Pathol. 158, 1757–1765 (2001).
Mesri, M., Wall, N.R., Li, J., Kim, R.W. & Altieri, D.C. Cancer gene therapy using a survivin mutant adenovirus. J. Clin. Invest. 108, 981–990 (2001).
O'Connor, D.S. et al. Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin. Proc. Natl. Acad. Sci. USA 97, 13103–13107 (2000).
Grossman, D., Kim, P.J., Schechner, J.S. & Altieri, D.C. Inhibition of melanoma tumor growth in vivo by survivin targeting. Proc. Natl. Acad. Sci. USA 98, 635–640 (2001).
Li, F. et al. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396, 580–584 (1998).
Carter, B.Z., Milella, M., Altieri, D.C. & Andreeff, M. Cytokine-regulated expression of survivin in myeloid leukemia. Blood 97, 2784–2790 (2001).
Mahboubi, K. et al. Interleukin-11 up-regulates survivin expression in endothelial cells through a signal transducer and activator of transcription-3 pathway. Lab. Invest. 81, 327–334 (2001).
Grossman, D. et al. Transgenic expression of survivin in keratinocytes counteracts UVB-induced apoptosis and cooperates with loss of p53. J. Clin. Invest. 108, 991–999 (2001).
Wheatley, S.P., Carvalho, A., Vagnarelli, P. & Earnshaw, W.C. INCENP is required for proper targeting of Survivin to the centromeres and the anaphase spindle during mitosis. Curr. Biol. 11, 886–890 (2001).
Fortugno, P. et al. Survivin exists in immunochemically distinct subcellular pools and is involved in spindle microtubule function. J. Cell Sci. (in the press).
Hart, C.E. et al. PDGFbeta receptor blockade inhibits intimal hyperplasia in the baboon. Circulation 99, 564–569 (1999).
Leppanen, O. et al. Intimal hyperplasia recurs after removal of PDGF-AB and -BB inhibition in the rat carotid artery injury model. Arterioscler. Thromb. Vasc. Biol. 20, E89–95 (2000).
Charles, R. et al. Ceramide-coated balloon catheters limit neointimal hyperplasia after stretch injury in carotid arteries. Circ. Res. 87, 282–288 (2000).
Olie, R.A. et al. A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy. Cancer Res. 60, 2805–2809 (2000).
Pennati, M. et al. Ribozyme-mediated attenuation of survivin expression sensitizes human melanoma cells to cisplatin-induced apoptosis. J. Clin. Invest. 109, 285–286 (2002).
Kanwar, J.R., Shen, W.P., Kanwar, R.K., Berg, R.W. & Krissansen, G.W. Effects of survivin antagonists on growth of established tumors and b7-1 immunogene therapy. J. Natl. Cancer Inst. 93, 1541–1552 (2001).
Signore, P.E. et al. Complete inhibition of intimal hyperplasia by perivascular delivery of paclitaxel in balloon-injured rat carotid arteries. J. Vasc. Interv. Radiol. 12, 79–88 (2001).
Sollott, S.J. et al. Taxol inhibits neointimal smooth muscle cell accumulation after angioplasty in the rat. J. Clin. Invest. 95, 1869–1876 (1995).
Fischman, D.L. et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N. Engl. J. Med. 331, 496–501 (1994).
Plescia, J., Conte, M.S., VanMeter, G., Ambrosini, G. & Altieri, D.C. Molecular identification of the cross-reacting epitope on αMβ2 integrin I domain recognized by anti-αIIbβ3 monoclonal antibody and its involvement in leukocyte adherence. J. Biol. Chem. 273, 20372–20377 (1998).
Acknowledgements
This work was supported by NIH grants HL54131, CA78810, CA90917 (to D.C.A.), and HL57665 and HL64793 (to W.C.S.).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Blanc-Brude, O., Yu, J., Simosa, H. et al. Inhibitor of apoptosis protein survivin regulates vascular injury. Nat Med 8, 987–994 (2002). https://doi.org/10.1038/nm750
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm750
This article is cited by
-
Inverse and reciprocal regulation of p53/p21 and Bmi-1 modulates vasculogenic differentiation of dental pulp stem cells
Cell Death & Disease (2021)
-
Notoginsenoside R1 inhibits vascular smooth muscle cell proliferation, migration and neointimal hyperplasia through PI3K/Akt signaling
Scientific Reports (2018)
-
Role of carbonic anhydrases in skin wound healing
Experimental & Molecular Medicine (2017)
-
Survivin selective inhibitor YM155 induce apoptosis in SK-NEP-1 Wilms tumor cells
BMC Cancer (2012)
-
Inhibition of STAT3 signaling prevents vascular smooth muscle cell proliferation and neointima formation
Basic Research in Cardiology (2012)